New cell therapy aims to rebuild immunity after cancer transplant
NCT ID NCT04640987
Summary
This early-phase study is testing whether a new cell therapy called T-allo10 is safe and can help rebuild the immune system after a stem cell transplant for children and young adults with serious blood cancers. The goal is to help the body fight cancer recurrence while trying to avoid a dangerous complication called graft-versus-host disease. Researchers will test different doses to find the safest and most effective amount to give.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Lucile Packard Children's Hospital
RECRUITINGPalo Alto, California, 94305, United States
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.